Skip to content

Sera Prognostics SERA EPS (Diluted)

EPS (Diluted) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$0.36
Labcorp Holdings logo
Labcorp HoldingsLH
$3.35+32.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2.24+15.5%
Natera, Inc. logo
Natera, Inc.NTRA
-$0.60-20.0%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$0.34+187%
Revvity logo
RevvityRVTY
$0.36+2.9%

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M-4.5%
Enterprise value$69.6M-0.5%
P/S1,250.3×+560×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's EPS (diluted)?
Sera Prognostics (SERA) reported EPS (diluted) of -$0.17 in Q1 2026.
How has Sera Prognostics's EPS (diluted) changed year-over-year?
Sera Prognostics's EPS (diluted) increased by 15.0% year-over-year, from -$0.20 to -$0.17.
What is the long-term trend for Sera Prognostics's EPS (diluted)?
Over 4 years (2021 to 2025), Sera Prognostics's EPS (diluted) has grown at a -44.4% compound annual growth rate (CAGR), from -$7.12 to -$0.68.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.